Weihua Sheng

688 total citations
35 papers, 586 citations indexed

About

Weihua Sheng is a scholar working on Genetics, Biotechnology and Oncology. According to data from OpenAlex, Weihua Sheng has authored 35 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 22 papers in Biotechnology and 17 papers in Oncology. Recurrent topics in Weihua Sheng's work include Virus-based gene therapy research (22 papers), Cancer Research and Treatments (22 papers) and Cytokine Signaling Pathways and Interactions (8 papers). Weihua Sheng is often cited by papers focused on Virus-based gene therapy research (22 papers), Cancer Research and Treatments (22 papers) and Cytokine Signaling Pathways and Interactions (8 papers). Weihua Sheng collaborates with scholars based in China, Canada and Taiwan. Weihua Sheng's co-authors include Jicheng Yang, Jim Xiang, Yufeng Xie, Jingcheng Miao, Zhenmin Ye, Haifeng Zhang, Yufeng Xie, Quan Huang, Mingzhong Li and Xiaoqiang Dong and has published in prestigious journals such as International Journal of Molecular Sciences, Cancer Letters and International Journal of Nanomedicine.

In The Last Decade

Weihua Sheng

35 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weihua Sheng China 15 322 167 152 118 85 35 586
Jingcheng Miao China 13 268 0.8× 103 0.6× 88 0.6× 49 0.4× 123 1.4× 39 530
Guangchao Xu China 15 359 1.1× 229 1.4× 78 0.5× 63 0.5× 126 1.5× 39 750
Diana D. Kang United States 15 540 1.7× 154 0.9× 89 0.6× 95 0.8× 63 0.7× 25 853
Hristo Iordanov United States 7 368 1.1× 61 0.4× 55 0.4× 73 0.6× 54 0.6× 9 563
Jason G. Fewell United States 18 704 2.2× 129 0.8× 56 0.4× 200 1.7× 94 1.1× 30 1.1k
Erin E Vaughan United States 12 407 1.3× 27 0.2× 104 0.7× 136 1.2× 40 0.5× 18 731
Ayelet Shabtay‐Orbach Israel 10 138 0.4× 173 1.0× 46 0.3× 29 0.2× 66 0.8× 13 449
Maedeh Talebi Iran 4 505 1.6× 50 0.3× 82 0.5× 202 1.7× 55 0.6× 5 658
Spyridon Champeris Tsaniras Greece 11 320 1.0× 106 0.6× 34 0.2× 45 0.4× 97 1.1× 28 568
Yongguang Yang United States 11 340 1.1× 65 0.4× 52 0.3× 52 0.4× 61 0.7× 18 620

Countries citing papers authored by Weihua Sheng

Since Specialization
Citations

This map shows the geographic impact of Weihua Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihua Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihua Sheng more than expected).

Fields of papers citing papers by Weihua Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weihua Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihua Sheng. The network helps show where Weihua Sheng may publish in the future.

Co-authorship network of co-authors of Weihua Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Weihua Sheng. A scholar is included among the top collaborators of Weihua Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weihua Sheng. Weihua Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yaodong, Li Tian, Weihua Sheng, Jingcheng Miao, & Jicheng Yang. (2013). Hypalgesia Effect of IL-24, a Quite New Mechanism for IL-24 Application in Cancer Treatment. Journal of Interferon & Cytokine Research. 33(10). 606–611. 8 indexed citations
2.
Sun, Peng, et al.. (2013). [Adenovirus-mediated interleukin-24 enhanced the antitumor effect of radiotherapy on nasopharyngeal carcinoma in vitro and in vivo].. PubMed. 48(11). 942–50. 1 indexed citations
3.
Sheng, Weihua, et al.. (2013). Adenovirus-mediated IL-24 expression enhances the chemosensitivity of multidrug-resistant gastric cancer cells to cisplatin. Oncology Reports. 30(5). 2288–2296. 12 indexed citations
4.
Xie, Yufeng, Haitao Lv, Weihua Sheng, et al.. (2011). Synergistic Tumor Suppression by Adenovirus-Mediated Inhibitor of Growth 4 and Interleukin-24 Gene Cotransfer in Hepatocarcinoma Cells. Cancer Biotherapy and Radiopharmaceuticals. 26(6). 681–695. 19 indexed citations
5.
Ling, Chunhua, et al.. (2011). [The in vitro and in vivo effects of adenovirus-mediated inhibitor of growth 4 and interleukin-24 co-expression on the radiosensitivity of human lung adenocarcinoma].. PubMed. 34(6). 413–8. 2 indexed citations
6.
Zhu, Yehan, et al.. (2011). [Effect of adenovirus-mediated ING4 and IL-24 co-expression on chemosensitivity to human lung adenocarcinoma in vitro and in vivo].. PubMed. 27(1). 85–94. 3 indexed citations
7.
Sheng, Weihua, Yu‐Feng Xie, Jingcheng Miao, et al.. (2010). The anti-tumor effect by adenovirus-mediated ING4 and IL-24 co-expression on hepatocellular carcinoma in vitro. Zhonghua weishengwuxue he mianyixue zazhi. 30(8). 695–703. 2 indexed citations
8.
Li, Zhengyi, Yufeng Xie, Weihua Sheng, et al.. (2010). Tumor-Suppressive Effect of Adenovirus-Mediated Inhibitor of Growth 4 Gene Transfer in Breast Carcinoma Cells In Vitro and In Vivo. Cancer Biotherapy and Radiopharmaceuticals. 25(4). 427–437. 18 indexed citations
9.
Sheng, Weihua, et al.. (2010). The In Vitro and In Vivo Antitumor Activity of Adenovirus-Mediated Interleukin-24 Expression for Laryngocarcinoma. Cancer Biotherapy and Radiopharmaceuticals. 25(1). 29–38. 14 indexed citations
10.
Yang, Jicheng, et al.. (2010). Antitumor activity of an adenovirus harboring human IL-24 in colon cancer. Molecular Biology Reports. 38(1). 395–401. 9 indexed citations
11.
Sheng, Weihua, et al.. (2009). Adenovirus-Mediated ING4 Expression Suppresses Pancreatic Carcinoma Cell Growth via Induction of Cell-Cycle Alteration, Apoptosis, and Inhibition of Tumor Angiogenesis. Cancer Biotherapy and Radiopharmaceuticals. 24(2). 261–269. 31 indexed citations
12.
Sheng, Weihua, et al.. (2009). [Adenovirus mediated IL-24 gene expression inhibits growth of human glioma cell in vitro].. PubMed. 25(2). 279–86. 1 indexed citations
13.
Wang, Xiao Hua, et al.. (2009). [Construction of adenovirus vector expressing IL-24 and E1A and its inhibition of SMMC-7721].. PubMed. 25(7). 1035–41. 1 indexed citations
14.
Miao, Jingcheng, et al.. (2009). [Interleukin 24 inhibits growth and induces apoptosis of osteosarcoma cells MG-63 in vitro and in vivo].. PubMed. 25(10). 1538–45. 1 indexed citations
15.
Su, Yan, Haifeng Zhang, Yufeng Xie, et al.. (2009). Recombinant Human Interleukin-24 Suppresses Gastric Carcinoma Cell GrowthIn VitroandIn Vivo. Cancer Investigation. 28(1). 85–93. 21 indexed citations
16.
Xie, Yufeng, Weihua Sheng, Jim Xiang, et al.. (2008). Recombinant Human IL-24 Suppresses Lung Carcinoma Cell Growth via Induction of Cell Apoptosis and Inhibition of Tumor Angiogenesis. Cancer Biotherapy and Radiopharmaceuticals. 23(3). 310–320. 25 indexed citations
17.
Pan, Xinting, Weihua Sheng, Yufeng Xie, et al.. (2008). Inhibition of Pancreatic Carcinoma Growth by Adenovirus-Mediated Human Interleukin-24 Expression in Animal Model. Cancer Biotherapy and Radiopharmaceuticals. 23(4). 425–434. 12 indexed citations
18.
19.
Wang, Xiaohua, Zhenmin Ye, Weihua Sheng, et al.. (2006). [The study of the growth-suppression and mechanisms of hepatocelluar carcinoma tumor in nude mice].. PubMed. 22(6). 925–30. 1 indexed citations
20.
Ye, Zhenmin, Yehan Zhu, Weihua Sheng, et al.. (2005). [The expression of recombinant protein of human interleukin-24 and its anti-tumor mechanism].. PubMed. 21(5). 719–24. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingcheng Miao Breakdown of academic impact, for papers by Guangchao Xu Breakdown of academic impact, for papers by Diana D. Kang Breakdown of academic impact, for papers by Hristo Iordanov Breakdown of academic impact, for papers by Jason G. Fewell Breakdown of academic impact, for papers by Erin E Vaughan Breakdown of academic impact, for papers by Ayelet Shabtay‐Orbach Breakdown of academic impact, for papers by Maedeh Talebi Breakdown of academic impact, for papers by Spyridon Champeris Tsaniras Breakdown of academic impact, for papers by Yongguang Yang
Rankless by CCL
2026